Invention Publication
- Patent Title: NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUS
-
Application No.: US18615472Application Date: 2024-03-25
-
Publication No.: US20240252622A1Publication Date: 2024-08-01
- Inventor: Etienne SIMON-LORIERE , Matthieu PROT , Xavier MONTAGUTELLI
- Applicant: INSTITUT PASTEUR
- Applicant Address: FR Paris Cedex 15
- Assignee: INSTITUT PASTEUR
- Current Assignee: INSTITUT PASTEUR
- Current Assignee Address: FR Paris Cedex 15
- Priority: EP 305140.4 2020.02.13
- Main IPC: A61K39/215
- IPC: A61K39/215 ; A61K39/00 ; C12N15/63 ; C12P19/34
Abstract:
The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-COV-2), comprising a nucleic acid construct encoding a SARS-COV-2 coronavirus Spike (S) protein antigen or a fragment thereof comprising the receptor-binding domain, wherein the nucleic acid construct sequence is codon-optimized for expression in 5 human.
Public/Granted literature
- US12171827B2 Nucleic acid vaccine against the SARS-CoV-2 coronavirus Public/Granted day:2024-12-24
Information query
